Tilray CEO Irwin Simon reacts to President Biden marijuana pardons
Irwin Simon, Tilray CEO, joins ‘Closing Bell’ to discuss about the importance of the White Condominium’s marijuana pardon info, what a schedule alternate would imply for marijuana in felony law…
Read more »
Tilray CEO on aquire of beer brands from Anheuser-Busch
Irwin Simon, Tilray chairman and CEO, joins ‘Thunder on the Avenue’ to be in contact about Tilray’s resolution to aquire some alcohol brands from Anheuser-Busch, the corporate’s resolution to wander…
Read more »
GW Pharma CEO on new cannabis-derived drug
GW Pharmaceuticals CEO Justin Gover discusses how the firm secured FDA approval for its cannabis-derived drug and what it says in regards to the potential ahead for cannabis-derived medicine.
Read more »
Canopy Enhance CEO on marijuana legalization
Canopy Enhance CEO Bruce Linton joins CNBC’s Deirdre Bosa to focus on about what it choice to him to maintain leisure marijuana legalized in Canada.
Read more »
Tilray CEO says the Canadian cannabis trade needs a drag-setter
Irwin Simon, Tilray CEO, joins ‘Closing Bell: Time beyond regulation’ to communicate regarding the firm’s M&A technique, earnings and Canada’s cannabis trade and regulation. For ranking entry to to stay…
Read more »
Columbia Care CEO on Canada cannabis legalization
Nicholas Vita, Columbia Care CEO, discusses how Canada’s legalization of leisure marijuana on Wednesday will private an label on the medicinal spend market and how it may per chance well…
Read more »
Trulieve CEO on multi-divulge operators blockbuster quarter and the capability forward for marijuana
Kim Rivers, Trulieve CEO, discusses the firm’s blowout earnings narrative. With CNBC’s Courtney Reagan and the Rapid Money traders, Guy Adami, Tim Seymour, Dan Nathan and Steve Grasso. For earn…
Read more »
Green Thumb CEO on cannabis improve: User search knowledge from is high
CNBC’s “Snort on the Road” team discusses pot stock ETFs and sector improve with Green Thumb Industries CEO Ben Kovler. For access to live and uncommon video from CNBC subscribe…
Read more »
Tilray CEO on first earnings file and rising cannabis substitute
Tilray CEO Brendan Kennedy discusses his firm’s enhance alongside the expansion of the clinical pot substitute as a total.
Read more »
Aurora Cannabis CEO on ‘uneven’ Canadian gross sales
Miguel Martin, Aurora Cannabis CEO, joins ‘Energy Lunch’ to talk about the trudge in gross sales the corporate is seeing in some substances of Canada and what it could perhaps…
Read more »